Global DPP IV Inhibitor Sales Market Report Forecast 2017-2021

June 2017 | 140 pages | ID: G43E0733039EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Eli Lilly and Company (US)
Merck & Co, Inc. (US)
Mitsubishi Tanabe Pharma Corporation (Japan)
Novartis AG (Switzerland)
Takeda Pharmaceutical Company Limited (Japan)
company 8
company 9

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 DPP IV INHIBITOR MARKET OVERVIEW

1.1 Product Overview and Scope of DPP IV Inhibitor
1.2 Classification of DPP IV Inhibitor
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of DPP IV Inhibitor
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 DPP IV Inhibitor Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of DPP IV Inhibitor (2012-2021)
  1.5.1 Global DPP IV Inhibitor Sales and Growth Rate (2012-2021)
  1.5.2 Global DPP IV Inhibitor Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON DPP IV INHIBITOR INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 DPP IV INHIBITOR MANUFACTURING COST ANALYSIS

3.1 DPP IV Inhibitor Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of DPP IV Inhibitor

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 DPP IV Inhibitor Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of DPP IV Inhibitor Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL DPP IV INHIBITOR COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global DPP IV Inhibitor Market Competition by Manufacturers
  5.1.1 Global DPP IV Inhibitor Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global DPP IV Inhibitor Revenue and Share by Manufacturers (2012-2017)
5.2 Global DPP IV Inhibitor (Volume and Value) by Type
  5.5.1 Global DPP IV Inhibitor Sales and Market Share by Type (2012-2017)
  5.5.2 Global DPP IV Inhibitor Revenue and Market Share by Type (2012-2017)
5.3 Global DPP IV Inhibitor (Volume and Value) by Regions
  5.3.1 Global DPP IV Inhibitor Sales and Market Share by Regions (2012-2017)
  5.3.2 Global DPP IV Inhibitor Revenue and Market Share by Regions (2012-2017)
5.4 Global DPP IV Inhibitor (Volume) by Application

6 UNITED STATES DPP IV INHIBITOR (VOLUME, VALUE AND SALES PRICE)

6.1 United States DPP IV Inhibitor Sales and Value (2012-2017)
  6.1.1 United States DPP IV Inhibitor Sales and Growth Rate (2012-2017)
  6.1.2 United States DPP IV Inhibitor Revenue and Growth Rate (2012-2017)
  6.1.3 United States DPP IV Inhibitor Sales Price Trend (2012-2017)
6.2 United States DPP IV Inhibitor Sales and Market Share by Manufacturers
6.3 United States DPP IV Inhibitor Sales and Market Share by Type
6.4 United States DPP IV Inhibitor Sales and Market Share by Application

7 CHINA DPP IV INHIBITOR (VOLUME, VALUE AND SALES PRICE)

7.1 China DPP IV Inhibitor Sales and Value (2012-2017)
  7.1.1 China DPP IV Inhibitor Sales and Growth Rate (2012-2017)
  7.1.2 China DPP IV Inhibitor Revenue and Growth Rate (2012-2017)
  7.1.3 China DPP IV Inhibitor Sales Price Trend (2012-2017)
7.2 China DPP IV Inhibitor Sales and Market Share by Manufacturers
7.3 China DPP IV Inhibitor Sales and Market Share by Type
7.4 China DPP IV Inhibitor Sales and Market Share by Application

8 EUROPE DPP IV INHIBITOR (VOLUME, VALUE AND SALES PRICE)

8.1 Europe DPP IV Inhibitor Sales and Value (2012-2017)
  8.1.1 Europe DPP IV Inhibitor Sales and Growth Rate (2012-2017)
  8.1.2 Europe DPP IV Inhibitor Revenue and Growth Rate (2012-2017)
  8.1.3 Europe DPP IV Inhibitor Sales Price Trend (2012-2017)
8.2 Europe DPP IV Inhibitor Sales and Market Share by Manufacturers
8.3 Europe DPP IV Inhibitor Sales and Market Share by Type
8.4 Europe DPP IV Inhibitor Sales and Market Share by Application

9 JAPAN DPP IV INHIBITOR (VOLUME, VALUE AND SALES PRICE)

9.1 Japan DPP IV Inhibitor Sales and Value (2012-2017)
  9.1.1 Japan DPP IV Inhibitor Sales and Growth Rate (2012-2017)
  9.1.2 Japan DPP IV Inhibitor Revenue and Growth Rate (2012-2017)
  9.1.3 Japan DPP IV Inhibitor Sales Price Trend (2012-2017)
9.2 Japan DPP IV Inhibitor Sales and Market Share by Manufacturers
9.3 Japan DPP IV Inhibitor Sales and Market Share by Type
9.4 Japan DPP IV Inhibitor Sales and Market Share by Application

10 GLOBAL DPP IV INHIBITOR MANUFACTURERS ANALYSIS

10.1 AstraZeneca Plc. (UK)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Boehringer Ingelheim GmbH (Germany)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Eli Lilly and Company (US)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Merck & Co, Inc. (US)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Mitsubishi Tanabe Pharma Corporation (Japan)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Novartis AG (Switzerland)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Takeda Pharmaceutical Company Limited (Japan)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 company
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 company
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL DPP IV INHIBITOR MARKET FORECAST (2017-2021)

13.1 Global DPP IV Inhibitor Sales, Revenue Forecast (2017-2021)
13.2 Global DPP IV Inhibitor Sales Forecast by Regions (2017-2021)
13.3 Global DPP IV Inhibitor Sales Forecast by Type (2017-2021)
13.4 Global DPP IV Inhibitor Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of DPP IV Inhibitor
Table Classification of DPP IV Inhibitor
Figure Global Sales Market Share of DPP IV Inhibitor by Type in 2015
Table Applications of DPP IV Inhibitor
Figure Global Sales Market Share of DPP IV Inhibitor by Application in 2015
Figure United States DPP IV Inhibitor Revenue and Growth Rate (2012-2021)
Figure China DPP IV Inhibitor Revenue and Growth Rate (2012-2021)
Figure Europe DPP IV Inhibitor Revenue and Growth Rate (2012-2021)
Figure Japan DPP IV Inhibitor Revenue and Growth Rate (2012-2021)
Figure Global DPP IV Inhibitor Sales and Growth Rate (2012-2021)
Figure Global DPP IV Inhibitor Revenue and Growth Rate (2012-2021)
Table Global DPP IV Inhibitor Sales of Key Manufacturers (2012-2017)
Table Global DPP IV Inhibitor Sales Share by Manufacturers (2012-2017)
Figure 2015 DPP IV Inhibitor Sales Share by Manufacturers
Figure 2016 DPP IV Inhibitor Sales Share by Manufacturers
Table Global DPP IV Inhibitor Revenue by Manufacturers (2012-2017)
Table Global DPP IV Inhibitor Revenue Share by Manufacturers (2012-2017)
Table 2015 Global DPP IV Inhibitor Revenue Share by Manufacturers
Table 2016 Global DPP IV Inhibitor Revenue Share by Manufacturers
Table Global DPP IV Inhibitor Sales and Market Share by Type (2012-2017)
Table Global DPP IV Inhibitor Sales Share by Type (2012-2017)
Figure Sales Market Share of DPP IV Inhibitor by Type (2012-2017)
Figure Global DPP IV Inhibitor Sales Growth Rate by Type (2012-2017)
Table Global DPP IV Inhibitor Revenue and Market Share by Type (2012-2017)
Table Global DPP IV Inhibitor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of DPP IV Inhibitor by Type (2012-2017)
Figure Global DPP IV Inhibitor Revenue Growth Rate by Type (2012-2017)
Table Global DPP IV Inhibitor Sales and Market Share by Regions (2012-2017)
Table Global DPP IV Inhibitor Sales Share by Regions (2012-2017)
Figure Sales Market Share of DPP IV Inhibitor by Regions (2012-2017)
Figure Global DPP IV Inhibitor Sales Growth Rate by Regions (2012-2017)
Table Global DPP IV Inhibitor Revenue and Market Share by Regions (2012-2017)
Table Global DPP IV Inhibitor Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of DPP IV Inhibitor by Regions (2012-2017)
Figure Global DPP IV Inhibitor Revenue Growth Rate by Regions (2012-2017)
Table Global DPP IV Inhibitor Sales and Market Share by Application (2012-2017)
Table Global DPP IV Inhibitor Sales Share by Application (2012-2017)
Figure Sales Market Share of DPP IV Inhibitor by Application (2012-2017)
Figure Global DPP IV Inhibitor Sales Growth Rate by Application (2012-2017)
Figure United States DPP IV Inhibitor Sales and Growth Rate (2012-2017)
Figure United States DPP IV Inhibitor Revenue and Growth Rate (2012-2017)
Figure United States DPP IV Inhibitor Sales Price Trend (2012-2017)
Table United States DPP IV Inhibitor Sales by Manufacturers (2012-2017)
Table United States DPP IV Inhibitor Market Share by Manufacturers (2012-2017)
Table United States DPP IV Inhibitor Sales by Type (2012-2017)
Table United States DPP IV Inhibitor Market Share by Type (2012-2017)
Table United States DPP IV Inhibitor Sales by Application (2012-2017)
Table United States DPP IV Inhibitor Market Share by Application (2012-2017)
Figure China DPP IV Inhibitor Sales and Growth Rate (2012-2017)
Figure China DPP IV Inhibitor Revenue and Growth Rate (2012-2017)
Figure China DPP IV Inhibitor Sales Price Trend (2012-2017)
Table China DPP IV Inhibitor Sales by Manufacturers (2012-2017)
Table China DPP IV Inhibitor Market Share by Manufacturers (2012-2017)
Table China DPP IV Inhibitor Sales by Type (2012-2017)
Table China DPP IV Inhibitor Market Share by Type (2012-2017)
Table China DPP IV Inhibitor Sales by Application (2012-2017)
Table China DPP IV Inhibitor Market Share by Application (2012-2017)
Figure Europe DPP IV Inhibitor Sales and Growth Rate (2012-2017)
Figure Europe DPP IV Inhibitor Revenue and Growth Rate (2012-2017)
Figure Europe DPP IV Inhibitor Sales Price Trend (2012-2017)
Table Europe DPP IV Inhibitor Sales by Manufacturers (2012-2017)
Table Europe DPP IV Inhibitor Market Share by Manufacturers (2012-2017)
Table Europe DPP IV Inhibitor Sales by Type (2012-2017)
Table Europe DPP IV Inhibitor Market Share by Type (2012-2017)
Table Europe DPP IV Inhibitor Sales by Application (2012-2017)
Table Europe DPP IV Inhibitor Market Share by Application (2012-2017)
Figure Japan DPP IV Inhibitor Sales and Growth Rate (2012-2017)
Figure Japan DPP IV Inhibitor Revenue and Growth Rate (2012-2017)
Figure Japan DPP IV Inhibitor Sales Price Trend (2012-2017)
Table Japan DPP IV Inhibitor Sales by Manufacturers (2012-2017)
Table Japan DPP IV Inhibitor Market Share by Manufacturers (2012-2017)
Table Japan DPP IV Inhibitor Sales by Type (2012-2017)
Table Japan DPP IV Inhibitor Market Share by Type (2012-2017)
Table Japan DPP IV Inhibitor Sales by Application (2012-2017)
Table Japan DPP IV Inhibitor Market Share by Application (2012-2017)
Table AstraZeneca Plc. (UK) Basic Information List
Table AstraZeneca Plc. (UK) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Plc. (UK) DPP IV Inhibitor Global Market Share (2012-2017)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH (Germany) DPP IV Inhibitor Global Market Share (2012-2017)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly and Company (US) DPP IV Inhibitor Global Market Share (2012-2017)
Table Merck & Co, Inc. (US) Basic Information List
Table Merck & Co, Inc. (US) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck & Co, Inc. (US) DPP IV Inhibitor Global Market Share (2012-2017)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mitsubishi Tanabe Pharma Corporation (Japan) DPP IV Inhibitor Global Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG (Switzerland) DPP IV Inhibitor Global Market Share (2012-2017)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Company Limited (Japan) DPP IV Inhibitor Global Market Share (2012-2017)
Table company 8 Basic Information List
Table company 8 DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 8 DPP IV Inhibitor Global Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 DPP IV Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 DPP IV Inhibitor Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of DPP IV Inhibitor
Figure Manufacturing Process Analysis of DPP IV Inhibitor
Figure DPP IV Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of DPP IV Inhibitor Major Manufacturers in 2015
Table Major Buyers of DPP IV Inhibitor
Table Distributors/Traders List
Figure Global DPP IV Inhibitor Sales and Growth Rate Forecast (2017-2021)
Figure Global DPP IV Inhibitor Revenue and Growth Rate Forecast (2017-2021)
Table Global DPP IV Inhibitor Sales Forecast by Regions (2017-2021)
Table Global DPP IV Inhibitor Sales Forecast by Type (2017-2021)
Table Global DPP IV Inhibitor Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Eli Lilly and Company (US)
Merck & Co, Inc. (US)
Mitsubishi Tanabe Pharma Corporation (Japan)
Novartis AG (Switzerland)
Takeda Pharmaceutical Company Limited (Japan)